恩华药业: 半年报监事会决议公告

Group 1 - The supervisory board of Jiangsu Enhua Pharmaceutical Co., Ltd. held its third meeting of the seventh session on July 18, 2025, with all three supervisors present, confirming compliance with legal and regulatory requirements for the meeting [1] - The supervisory board reviewed and approved the procedures for the preparation and review of the company's 2025 semi-annual report, affirming that the report accurately reflects the company's financial status, operational results, corporate governance, business development, and major risks [1] - The supervisory board also approved the achievement of the first unlock condition for the restricted stock under the 2024 stock incentive plan, confirming that 750 eligible incentive recipients met the criteria for unlocking their restricted stocks [2]